Statements (53)
Predicate | Object |
---|---|
gptkbp:instanceOf |
chemical compound
|
gptkbp:activities |
specific cancer cell lines
|
gptkbp:application |
potential cancer therapy
|
gptkbp:availability |
research purposes only
|
gptkbp:avionics |
various derivatives exist
|
gptkbp:benefits |
improved patient outcomes
|
gptkbp:built |
toxicity assessment
|
gptkbp:chemicalFormula |
lipophilic
small molecule contains thiazole ring C20H24N2O2S interacts with cellular pathways |
gptkbp:clinicalTrials |
ongoing
potential breakthrough in therapy. |
gptkbp:collaborations |
international research teams
various research institutions with pharmaceutical companies |
gptkbp:compatibleWith |
high
|
gptkbp:composedOf |
multi-step organic synthesis
|
gptkbp:dissolved |
soluble in DMSO
|
gptkbp:established |
scientists_at_the_University_of_California
|
gptkbp:financial_aid |
stable under normal conditions
|
gptkbp:funding |
grants from cancer research organizations
|
gptkbp:future_plans |
preclinical research
clinical trials planned understanding resistance mechanisms |
https://www.w3.org/2000/01/rdf-schema#label |
SR 830
|
gptkbp:impact |
potential toxicity
|
gptkbp:is_aimed_at |
various types of cancer
|
gptkbp:is_used_in |
research on cancer
|
gptkbp:isATypeOf |
123456-78-9
|
gptkbp:market |
oncology drugs
|
gptkbp:notableWork |
new treatment options for cancer patients
significant in cancer treatment |
gptkbp:origin |
N-(4-(4-(dimethylamino)phenyl)-2-thiazolyl)-N'-phenylurea
|
gptkbp:patentAssignee |
gptkb:University_of_California
|
gptkbp:patentStatus |
patented
|
gptkbp:publications |
multiple peer-reviewed articles
|
gptkbp:regulatoryCompliance |
not yet approved for clinical use
|
gptkbp:related_to |
other thiazole derivatives
|
gptkbp:reportsTo |
in 2005
|
gptkbp:research |
limited human data
promising results in vitro |
gptkbp:research_areas |
oncology
|
gptkbp:research_focus |
tumor microenvironment
high among researchers |
gptkbp:safety |
handle with care
|
gptkbp:storage |
cool, dry place
|
gptkbp:targets |
protein kinase
|
gptkbp:technology |
exploration of combination therapies
|
gptkbp:triggerType |
inhibits cell proliferation
inhibits specific enzymes |
gptkbp:weight |
344.48 g/mol
|